Sensus Healthcare, Inc. Stock

Equities

SRTS

US81728J1097

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-05-10 pm EDT 5-day change 1st Jan Change
5.29 USD +38.85% Intraday chart for Sensus Healthcare, Inc. +44.93% +124.15%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 26.3M Sales 2025 * 32.26M Capitalization 86.72M
Net income 2024 * - Net income 2025 * 3M EV / Sales 2024 * 3.3 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.69 x
P/E ratio 2024 *
118 x
P/E ratio 2025 *
26.5 x
Employees 35
Yield 2024 *
-
Yield 2025 *
-
Free-Float 76.13%
More Fundamentals * Assessed data
Dynamic Chart
1 day+38.85%
1 week+44.93%
Current month+40.69%
1 month+57.91%
3 months+36.34%
6 months+178.42%
Current year+124.15%
More quotes
1 week
3.61
Extreme 3.61
5.45
1 month
3.09
Extreme 3.09
5.45
Current year
2.36
Extreme 2.3648
5.45
1 year
1.79
Extreme 1.79
5.45
3 years
1.79
Extreme 1.79
15.25
5 years
1.76
Extreme 1.7603
15.25
10 years
1.76
Extreme 1.7603
15.25
More quotes
Managers TitleAgeSince
Founder 71 10-05-06
Chief Executive Officer 71 10-05-06
Director of Finance/CFO 52 14-12-31
Members of the board TitleAgeSince
Chief Executive Officer 71 10-05-06
Director/Board Member 71 16-07-20
Director/Board Member 77 12-01-31
More insiders
Date Price Change Volume
24-05-10 5.29 +38.85% 19,744,915
24-05-09 3.81 -0.52% 980,624
24-05-08 3.83 +1.32% 158,107
24-05-07 3.78 +0.53% 261,029
24-05-06 3.76 +3.01% 101,216

Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT

More quotes
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
5.29 USD
Average target price
9 USD
Spread / Average Target
+70.13%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW